Search research articles
Contact Us
Filters
Showing results (101-110 of 124) with videos related to
Page
of 13
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 25, 1998
Clinical impact of pharmacokinetically-guided dose adaptation of 5-fluorouracil: results from a multicentric randomized trial in patients with locally advanced head and neck carcinomas
R Fety, F Rolland, M Barberi-Heyob, et al.
European Annals of Otorhinolaryngology, Head and Neck Diseases
|
January 22, 2013
Initial staging for squamous cell carcinoma of the mouth, larynx and pharynx (except nasopharynx). Part 3: general assessment. 2012 SFORL recommendations
E de Monès, S Vergez, B Barry, et al.
ESMO Open
|
November 7, 2025
MOVIE phase II trial of tremelimumab plus durvalumab combined with metronomic oral vinorelbine in patients with head and neck cancer
E Borcoman, A Hervieu, C Cropet, et al.
International Journal of Obesity (2005)
|
February 25, 2009
Prevalence of overweight in 6- to 15-year-old children in central/western France from 1996 to 2006: trends toward stabilization
S Péneau, B Salanave, L Maillard-Teyssier, et al.
Bulletin Du Cancer
|
September 12, 2009
[Locally advanced head and neck cancers: recommendations of an expert panel and perspectives for the use of TPF regimen (docetaxel, cisplatin and fluoro-uracil) as induction therapy]
E Bardet, J Bourhis, L Cals, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 6, 2014
Combining gemcitabine, cisplatin, and ifosfamide (GIP) is active in patients with relapsed metastatic germ-cell tumors (GCT): a prospective multicenter GETUG phase II trial
K Fizazi, G Gravis, A Flechon, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 25, 2003
Results of randomised phase II studies comparing S16020 with methotrexate in patients with recurrent head and neck cancer
X Pivot, A Awada, D Gedouin, et al.
British Journal of Pharmacology
|
February 18, 2009
Statins and fenofibrate affect skeletal muscle chloride conductance in rats by differently impairing ClC-1 channel regulation and expression
S Pierno, G M Camerino, V Cippone, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 25, 2015
First-line treatment with sunitinib for type 1 and type 2 locally advanced or metastatic papillary renal cell carcinoma: a phase II study (SUPAP) by the French Genitourinary Group (GETUG)†
A Ravaud, S Oudard, M De Fromont, et al.
The British Journal of Nutrition
|
March 14, 2007
Central adiposity in Brazilian schoolchildren aged 7-10 years
M A A de Assis, M F Rolland-Cachera, F A G de Vasconcelos, et al.
Page
of 13
Search research articles
Search
Showing results (101-110 of 124) with videos related to
Sort By:
Page
of 13
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 25, 1998
Clinical impact of pharmacokinetically-guided dose adaptation of 5-fluorouracil: results from a multicentric randomized trial in patients with locally advanced head and neck carcinomas
R Fety, F Rolland, M Barberi-Heyob, et al.
European Annals of Otorhinolaryngology, Head and Neck Diseases
|
January 22, 2013
Initial staging for squamous cell carcinoma of the mouth, larynx and pharynx (except nasopharynx). Part 3: general assessment. 2012 SFORL recommendations
E de Monès, S Vergez, B Barry, et al.
ESMO Open
|
November 7, 2025
MOVIE phase II trial of tremelimumab plus durvalumab combined with metronomic oral vinorelbine in patients with head and neck cancer
E Borcoman, A Hervieu, C Cropet, et al.
International Journal of Obesity (2005)
|
February 25, 2009
Prevalence of overweight in 6- to 15-year-old children in central/western France from 1996 to 2006: trends toward stabilization
S Péneau, B Salanave, L Maillard-Teyssier, et al.
Bulletin Du Cancer
|
September 12, 2009
[Locally advanced head and neck cancers: recommendations of an expert panel and perspectives for the use of TPF regimen (docetaxel, cisplatin and fluoro-uracil) as induction therapy]
E Bardet, J Bourhis, L Cals, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 6, 2014
Combining gemcitabine, cisplatin, and ifosfamide (GIP) is active in patients with relapsed metastatic germ-cell tumors (GCT): a prospective multicenter GETUG phase II trial
K Fizazi, G Gravis, A Flechon, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 25, 2003
Results of randomised phase II studies comparing S16020 with methotrexate in patients with recurrent head and neck cancer
X Pivot, A Awada, D Gedouin, et al.
British Journal of Pharmacology
|
February 18, 2009
Statins and fenofibrate affect skeletal muscle chloride conductance in rats by differently impairing ClC-1 channel regulation and expression
S Pierno, G M Camerino, V Cippone, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 25, 2015
First-line treatment with sunitinib for type 1 and type 2 locally advanced or metastatic papillary renal cell carcinoma: a phase II study (SUPAP) by the French Genitourinary Group (GETUG)†
A Ravaud, S Oudard, M De Fromont, et al.
The British Journal of Nutrition
|
March 14, 2007
Central adiposity in Brazilian schoolchildren aged 7-10 years
M A A de Assis, M F Rolland-Cachera, F A G de Vasconcelos, et al.
Page
of 13